Literature DB >> 30401324

Pearls and pitfalls in the diagnosis of cough variant asthma.

William M Corrao.   

Abstract

Cough alone may sometimes be the sole presenting symptom of asthma. Patients experience cough without wheeze or shortness of breath and with normal baseline pulmonary function test results. These patients do, however, demonstrate bronchial hyperreactivity. They also respond to specific traditional asthma therapy. These patients are considered to have a specific asthma phenotype: cough variant asthma (CVA).In prospective studies of patients with chronic cough, an average of 25% have CVA. Patients have chronic cough, normal baseline pulmonary function tests, positive bronchial inhalation challenge results, and response to specific asthma therapy. What makes these patients cough is still unknown. The cough reflex is complex. The specific cause of cough in CVA may be similar to cough mechanisms seen in typical bronchial asthma.All therapies for typical bronchial asthma have been successful in controlling cough in patients with CVA. The overall prognosis of CVA is excellent, with most patients requiring chronic inhaled corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30401324     DOI: 10.2500/aap.2018.39.4168

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  4 in total

1.  Atopic dermatitis: A disease "More common in families that sneeze and wheeze".

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2018-11-01       Impact factor: 2.587

2.  The risk of preschool asthma at 2-4 years is not associated with leukocyte telomere length at birth or at 1 year of age.

Authors:  Dong In Suh; Mi-Jin Kang; Yoon Mee Park; Jun-Kyu Lee; So-Yeon Lee; Youn Ho Sheen; Kyung Won Kim; Kangmo Ahn; Soo-Jong Hong
Journal:  Asia Pac Allergy       Date:  2019-10-14

3.  Suhuang Antitussive Capsule Ameliorates Corticosteroid Insensitivity in Cough Variant Asthma Guinea Pigs by Inhibiting p38 MAPK Signal Pathway.

Authors:  Tianyi Lyu; Demin Li; Haojun Zhang; Siyi Chen; Daowen Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-17       Impact factor: 2.629

4.  Exploration in the Mechanism of Zhisou San for the Treatment of Cough Variant Asthma Based on Network Pharmacology.

Authors:  De-Hai Guo; Jin-Ping Hao; Xing-Jie Li; Qing Miao; Qiong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.